专利检索 ap:("Wei Chen" OR "Antoni Krasinski") AND inv:"Antoni Krasinski" 第 2 页

11.

发明申请
FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESUFLONAMIDES AS CCR2 MODULATORS FOR THE TREATMENT OF INFLAMMATION 有权
标题翻译： FUSED HETEROARYL PYRIDYL和PHENYL BENZENESUFLONAMIDES作为CCR2调节剂用于治疗感染

公开(公告)号：US20110319433A1

公开(公告)日：2011-12-29

申请号：US12976768

申请日：2010-12-22

申请人： Antoni Krasinski , Sreenivas Punna , Solomon Ungashe , Qiang Wang , Yibin Zeng

发明人： Antoni Krasinski , Sreenivas Punna , Solomon Ungashe , Qiang Wang , Yibin Zeng

IPC分类号： A61K31/519 , C07D473/00 , A61K31/52 , A61P9/10 , A61P25/00 , C12N5/071 , A61P13/12 , A61P29/00 , A61P3/04 , A61P3/10 , A61P11/00 , C07D487/04 , A61P1/00

CPC分类号： C07D487/04 , C07D213/79 , C07D213/81 , C07D213/84 , C07D471/04 , C07D471/12 , C07D473/00

摘要： Compounds are provided that act as potent antagonists of the CCR2 receptor. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases and as controls in assays for the identification of CCR2 antagonists.

摘要翻译： 提供了作为CCR2受体的有效拮抗剂的化合物。化合物通常为芳基磺酰胺衍生物，并且可用于药物组合物，用于治疗CCR2介导的疾病的方法和用于鉴定CCR2拮抗剂的测定中的对照。